XML 33 R25.htm IDEA: XBRL DOCUMENT v3.25.2
Net Loss Per Share
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Net Loss Per Share

17. Net loss per share

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

($ in thousands)

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net loss for basic and diluted calculation

 

$

(15,430

)

 

$

(12,241

)

 

$

(19,249

)

 

$

(21,012

)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding for calculating basic and diluted loss per share(*)

 

 

13,098,825

 

 

 

12,617,128

 

 

 

12,948,189

 

 

 

12,581,608

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per share(*)

 

$

(1.18

)

 

$

(0.97

)

 

$

(1.49

)

 

$

(1.67

)

 

* -

Prior year per-share amounts and number of shares, as applicable, have been revised to reflect the Reverse Stock Split effective November 29, 2024.

 

For purposes of computing diluted loss per share, weighted average common shares outstanding do not include potentially dilutive securities that are anti-dilutive, as shown below.

 

 

For the three and six months ended June 30,

 

 

 

2025

 

 

2024

 

Anti-dilutive securities excluded from calculating dilutive loss per share:

 

 

 

 

 

 

Shares of common stock issuable under stock option plans outstanding

 

 

206,405

 

 

 

238,630

 

Shares of common stock issuable upon vesting of RSUs

 

 

1,974,750

 

 

 

1,152,168

 

Potential common shares excluded from diluted net loss per share calculation

 

 

2,181,155

 

 

 

1,390,798

 

The Original Warrants, which were exercised in full on June 30, 2025, were deemed to be participating securities as the holders of the Original Warrants had the ability to participate in distributions, as defined in the warrant agreement. However, the holders of the Original Warrants do not have an obligation to share in the Company's losses. As such, losses are attributed entirely to the common stockholders. For the period the Original Warrants were outstanding, they had no dilutive effect on our diluted loss per share for the three and six months ended June 30, 2025.